Literature DB >> 12955406

Insulin addition after ischemia improves recovery of function equal to ischemic preconditioning in rat heart.

Ulrich Fischer-Rasokat1, Friedhelm Beyersdorf, Torsten Doenst.   

Abstract

BACKGROUND: Ischemic preconditioning (IPC) is considered the most potent mechanism to improve ischemia tolerance. We have demonstrated that insulin addition during reperfusion improves recovery of function in the isolated working rat heart. We herein compare the relative importance of these two mechanisms in improving recovery of postischemic function.
METHODS: Isolated working rat hearts were perfused with Krebs-Henseleit buffer containing glucose (5 mmol/l) plus oleate (0.4 mmol/l) for 20 min and were then subjected to 15 min of ischemia followed by 35 min of reperfusion. IPC was achieved by an ischemic period of fi ve minutes followed by 10 minutes of reperfusion before ischemia. Insulin (1 mU/ml) was or was not added at the beginning of reperfusion. Wortmannin (WM, 3 micro mol/l), an inhibitor of phosphatidylinositol 3-kinase, was or was not present in the perfusate from the beginning of the experiments. We measured glucose uptake with [2-(3)H]glucose, cardiac power and tissue metabolite content at the end of the experiments.
RESULTS: Cardiac power before ischemia ranged from 7.17 to 10.4 mW. After ischemia, cardiac power recovered to 65.7 +/- 3.8% (Control). Insulin significantly improved recovery (96.3 +/- 10.8%, p < 0.05 vs. Control). This effect was also achieved by IPC (recovery 86.2 +/- 6.2%, p < 0.05). The effects of insulin and IPC were not additive (recovery 83.4 +/- 6.2%, p < 0.05). WM fully inhibited the effects of both insulin and IPC (69.5 +/- 3.3, 72.0 +/- 6.9, respectively). Basal glucose uptake ranged from 2.53 to 3.46 micro mol/gdry, and was significantly lower after ischemia in the presence of WM.
CONCLUSIONS: Insulin is a potent tool to improve postischemic contractile function. The improvement of recovery afforded by insulin added after ischemia may be mediated through a similar mechanism as ischemic preconditioning.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955406     DOI: 10.1007/s00395-003-0414-y

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  6 in total

Review 1.  Isolated heart models: cardiovascular system studies and technological advances.

Authors:  Veronika Olejnickova; Marie Novakova; Ivo Provaznik
Journal:  Med Biol Eng Comput       Date:  2015-03-15       Impact factor: 2.602

2.  GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction.

Authors:  T Dung Nguyen; Yasushige Shingu; Paulo A Amorim; Christina Schenkl; Michael Schwarzer; Torsten Doenst
Journal:  J Cardiovasc Transl Res       Date:  2018-02-20       Impact factor: 4.132

Review 3.  Myocardial protection in man--from research concept to clinical practice.

Authors:  Dennis V Cokkinos; Costas Pantos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 4.  Insulin signaling in the heart.

Authors:  E Dale Abel
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-31       Impact factor: 5.900

5.  Increased Protein Tyrosine Phosphatase 1B (PTP1B) Activity and Cardiac Insulin Resistance Precede Mitochondrial and Contractile Dysfunction in Pressure-Overloaded Hearts.

Authors:  T Dung Nguyen; Michael Schwarzer; Andrea Schrepper; Paulo A Amorim; Daniel Blum; Claudia Hain; Gloria Faerber; Judith Haendeler; Joachim Altschmied; Torsten Doenst
Journal:  J Am Heart Assoc       Date:  2018-06-21       Impact factor: 5.501

6.  AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury.

Authors:  Lele Ji; Xing Zhang; Wenchong Liu; Qichao Huang; Weidong Yang; Feng Fu; Heng Ma; Hui Su; Haichang Wang; Jing Wang; Haifeng Zhang; Feng Gao
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.